Received: 19 November 2019
Accepted: 24 April 2020
First Online: 13 May 2020
Ethics approval and consent to participate
: The study was performed in accordance with Good Clinical Practice guidelines and the World Medical Association Declaration of Helsinki. Patients provided written informed consent. Approvals for the study protocol were obtained from independent ethics committees.
: Not applicable.
: AP reports that his institution received research funding from Nanostring Technologies, Roche, and Novartis. AP reports consulting and lecture fees from Nanostring Technologies, Roche, Novartis, Pfizer, Oncolytics Biotech, Amgen, Lilly, MSD, and PUMA.